NVR 7P5 (Afinitor 7.5 mg)
Generic Name: everolimus
Pill with imprint NVR 7P5 is White, Elliptical / Oval and has been identified as Afinitor 7.5 mg. It is supplied by Novartis Pharmaceuticals.
Afinitor is used in the treatment of breast cancer; neuroendocrine carcinoma; pancreatic cancer; renal angiomyolipoma; renal cell carcinoma (and more), and belongs to the drug classes mTOR inhibitors, selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Afinitor 7.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for NVR 7P5
Afinitor
- Generic Name:
- everolimus
- Imprint:
- NVR 7P5
- Strength:
- 7.5 mg
- Color:
- White
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- MTOR inhibitors
Selective immunosuppressants - Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Novartis Pharmaceuticals
- Inactive Ingredients:
- butylated hydroxytoluene
crospovidone
hypromelloses
lactose anhydrous
lactose monohydrate
magnesium stearate
Note: Inactive ingredients may vary.
More about Afinitor (everolimus)
- Afinitor Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 13 Reviews
- Drug class: mTOR inhibitors
Consumer resources
Other brands: Zortress
Professional resources
Other Formulations
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
